Latest California Healthline Stories
Democrats Roll the Dice on Sweeping Abortion Rights Bill — Again
Capitol Hill lawmakers mobilize to support a bill that would write abortion protections into federal law. Unlikely to succeed, the exercise follows a tactic that proved unsuccessful in 1992.
‘An Arm and a Leg’: They Turned Grief Into Action
This episode highlights how New York enacted a charity care law, one of the precursors to the federal provision on charity care in the Affordable Care Act.
Congress Cites KHN Investigation in Probe of National Academies
The House oversight committee is requesting conflict-of-interest disclosure forms from a National Academies committee studying organ transplants. KHN previously reported on apparent conflicts among members of a committee studying drug waste.
California’s Reboot of Troubled Medi-Cal Puts Pressure on Health Plans
The nine commercial insurers in Medi-Cal must reapply by submitting bids for new contracts. The state hopes the process will improve care for low-income residents and tighten accountability, something critics say has been missing.
Covid-Overwhelmed Hospitals Postpone Cancer Care and Other Treatment
Patients with advanced cancer and heart disease are among those who have had to have surgeries and other treatments delayed and rescheduled as a high number of critically ill, unvaccinated covid patients strain the medical system.
Scientists Examine Kids’ Unique Immune Systems as More Fall Victim to Covid
Doctors are trying to figure out why some kids become much sicker than others and, in rare cases, don’t survive.
Leader of California’s Muscular Obamacare Exchange to Step Down
Peter Lee helped create Covered California, which has been lauded as a national example among the Affordable Care Act’s insurance marketplaces, and he fiercely opposed Republican efforts to repeal the federal health reform law.
KHN’s ‘What the Health?’: Much Ado About Drug Prices
Democrats have hit a snag in their effort to compile a $3.5 trillion social-spending bill this fall — moderates are resisting support for Medicare drug price negotiation provisions that would pay for many of the measure’s health benefit improvements. Meanwhile, the new abortion restrictions in Texas have moved the divisive issue back to the political front burner. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Shefali Luthra of The 19th join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interview’s KHN’s Phil Galewitz about the latest KHN-NPR “Bill of the Month” installment, about two similar jaw surgeries with very different price tags.
When Covid Deaths Are Dismissed or Stigmatized, Grief Is Mixed With Shame and Anger
After their brother died, two sisters faced a barrage of misinformation, pandemic denialism and blaming questions. Grief experts say that makes covid-19 the newest kind of “disenfranchising death.”
How Fauci and the NIH Got Ahead of the FDA and CDC in Backing Boosters
With real-time data streaming in from highly specialized researchers in the U.S. and abroad, NIH scientists became convinced that boosting the covid-19 vaccine was needed to save lives, prompting the president to announce a plan with a Sept. 20 start date. Scientists at the regulatory agencies weren’t yet convinced. A meeting Friday will determine what happens next. Here’s the story from behind the scenes.